Cargando…
A case–control study investigating food addiction in Parkinson patients
Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but dat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149641/ https://www.ncbi.nlm.nih.gov/pubmed/34035366 http://dx.doi.org/10.1038/s41598-021-90266-8 |
_version_ | 1783697989377720320 |
---|---|
author | de Chazeron, Ingrid Durif, F. Lambert, C. Chereau-Boudet, I. Fantini, M. L. Marques, A. Derost, P. Debilly, B. Brousse, G. Boirie, Y. Llorca, P. M. |
author_facet | de Chazeron, Ingrid Durif, F. Lambert, C. Chereau-Boudet, I. Fantini, M. L. Marques, A. Derost, P. Debilly, B. Brousse, G. Boirie, Y. Llorca, P. M. |
author_sort | de Chazeron, Ingrid |
collection | PubMed |
description | Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD. |
format | Online Article Text |
id | pubmed-8149641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81496412021-05-26 A case–control study investigating food addiction in Parkinson patients de Chazeron, Ingrid Durif, F. Lambert, C. Chereau-Boudet, I. Fantini, M. L. Marques, A. Derost, P. Debilly, B. Brousse, G. Boirie, Y. Llorca, P. M. Sci Rep Article Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD. Nature Publishing Group UK 2021-05-25 /pmc/articles/PMC8149641/ /pubmed/34035366 http://dx.doi.org/10.1038/s41598-021-90266-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article de Chazeron, Ingrid Durif, F. Lambert, C. Chereau-Boudet, I. Fantini, M. L. Marques, A. Derost, P. Debilly, B. Brousse, G. Boirie, Y. Llorca, P. M. A case–control study investigating food addiction in Parkinson patients |
title | A case–control study investigating food addiction in Parkinson patients |
title_full | A case–control study investigating food addiction in Parkinson patients |
title_fullStr | A case–control study investigating food addiction in Parkinson patients |
title_full_unstemmed | A case–control study investigating food addiction in Parkinson patients |
title_short | A case–control study investigating food addiction in Parkinson patients |
title_sort | case–control study investigating food addiction in parkinson patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149641/ https://www.ncbi.nlm.nih.gov/pubmed/34035366 http://dx.doi.org/10.1038/s41598-021-90266-8 |
work_keys_str_mv | AT dechazeroningrid acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT duriff acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT lambertc acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT chereauboudeti acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT fantiniml acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT marquesa acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT derostp acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT debillyb acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT brousseg acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT boiriey acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT llorcapm acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT dechazeroningrid casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT duriff casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT lambertc casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT chereauboudeti casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT fantiniml casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT marquesa casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT derostp casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT debillyb casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT brousseg casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT boiriey casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients AT llorcapm casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients |